SCHEMBL3454488

SCHEMBL3454488

CCS(=O)(=O)c1ccc(C2=CC(C3CCC3)=C(C3CCNCC3)NC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.34
RORC P51449 2/20 0.34
HRH4 Q9H3N8 1/20 0.32
PLAT P00750 1/20 0.31
PSIP1 O75475 1/20 0.31
MLNR O43193 3/20 0.31
CYP2D6 P10635 1/20 0.31
JAK2 O60674 1/20 0.31
HTR6 P50406 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
KIT P10721 1/20 0.30
IKBKB O14920 2/20 0.30
MAPK8 P45983 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3454499 0.75 HTR6 (0.33) RORCPLATPSIP1MLNRCYP2D6
SCHEMBL22324769 0.69 SLC18A3 (0.48) RORCPSIP1HTR6
SCHEMBL3454494 0.68 GABRA2 (0.33) CNR2RORCPLATJAK2HTR6
SCHEMBL3072064 0.68 SYK (0.44) RORCPLATMLNRCYP2D6JAK2
SCHEMBL3454570 0.64 NMT1 (0.33) PLATHTR6
SCHEMBL5051360 0.63 RORC (0.60) RORCCA1CA2PTGS1PTGS2
SCHEMBL4777240 0.62 GBA1 (0.54) CNR2RORCPSIP1MLNRHTR6
SCHEMBL10181940 0.61 RORC (0.62) CNR2RORCPSIP1
Hydrochloric Acid SCHEMBL4773264 0.61 GBA1 (0.53) CNR2RORCPSIP1MLNRHTR6
SCHEMBL3454502 0.60 PSIP1 (0.34) PSIP1MLNRCYP2D6JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166850-A1 NEW HETEOCYCLIC H3 ANTAGONISTS High Point Pharmaceuticals, LLC (US) 2010-03-31 EP disclosed
WO-2008154126-A1 NEW HETEOCYCLIC H3 ANTAGONISTS HIGH POINT PHARMACEUTICALS, LLC (US) 2008-12-18 WO disclosed